Dna n6-methyladenine demethylase alkbh1 enhances osteogenic differentiation of human mscs

Bone Research

Volumn 4, Issue 1, 2016, Pages

  Zhou, Chenchen ^a   Liu, Yuting ^a   Li, Xiaobing ^a   Zou, Jing ^a   Zou, Shujuan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85019023809     PISSN: 20954700     EISSN: 20956231     Source Type: Journal    
DOI: 10.1038/boneres.2016.33     Document Type: Article

References (45)

1. Nombela-Arrieta C, Ritz J, Silberstein LE. The elusive nature and function of mesenchymal stem cells. Nat Rev Mol Cell Biol 2011; 12: 126–131.
2. Deng P, Chen QM, Hong C et al. Histone methyltransferases and demethylases: regulators in balancing osteogenic and adipogenic differentiation of mesenchymal stem cells. Int J Oral Sci 2015; 7: 197–204.
3. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008; 2: 313–319.
4. Bianco P, Cao X, Frenette PS et al. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nat Med 2013; 19: 35–42.
5. Yu S, Zhu K, Lai Y et al. atf4 promotes beta-catenin expression and osteoblastic differentiation of bone marrow mesenchymal stem cells. Int J Biol Sci 2013; 9: 256–266.
6. Crane JL, Zhao L, Frye JS et al. IGF-1 signaling is essential for differentiation of mesenchymal stem cells for peak bone mass. Bone Res 2013; 1: 186–194.
7. Rahman MS, Akhtar N, Jamil HM et al. TGF-beta/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone Res 2015; 3: 15005.
8. Chiavistelli S, Giustina A, Mazziotti G. Parathyroid hormone pulsatility: physiological and clinical aspects. Bone Res 2015; 3: 14049.
9. Yuan Q, Sato T, Densmore M et al. Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/-mice. PLoS Genet 2012; 8: e1002726.
10. Yuan Q, Sato T, Densmore M et al. FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH. J Bone Miner Res 2011; 26: 2026–2035.
11. Wu TP, Wang T, Seetin MG et al. DNA methylation on N(6)-adenine in mammalian embryonic stem cells. Nature 2016; 532: 329–333.
12. Guo H, Zhu P, Yan L et al. The DNA methylation landscape of human early embryos. Nature 2014; 511: 606–610.
13. Bonder MJ, Kasela S, Kals M et al. Genetic and epigenetic regulation of gene expression in fetal and adult human livers. BMC Genomics 2014; 15: 860.
14. Wu Y, Zhang S, Yuan Q. N(6)-methyladenosine methyltransferases and demethylases: new regulators of stem cell pluripotency and differen-tiation. Stem Cells Dev 2016; 25: 1050–1059.
15. Tsankov AM, Gu H, Akopian V et al. Transcription factor binding dynamics during human ES cell differentiation. Nature 2015; 518: 344–349.
16. Ye C, Li L. 5-hydroxymethylcytosine: a new insight into epigenetics in cancer. Cancer Biol Ther 2014; 15: 10–15.
17. Ooi SK, O'Donnell AH, Bestor TH. Mammalian cytosine methylation at a glance. J Cell Sci 2009; 122: 2787–2791.
18. Pastor WA, Aravind L, Rao A. TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat Rev Mol Cell Biol 2013; 14: 341–356.
19. Hu L, Li Z, Cheng J et al. Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell 2013; 155: 1545–1555.
20. Tahiliani M, Koh KP, Shen Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324: 930–935.
21. Hon GC, Song CX, Du T et al. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol Cell 2014; 56: 286–297.
22. Fu G, Ren A, Qiu Y et al. Epigenetic regulation of osteogenic differentiation of mesenchymal stem cells. Curr Stem Cell Res Ther 2016; 11: 235–246.
23. Dansranjavin T, Krehl S, Mueller T et al. The role of promoter CpG methylation in the epigenetic control of stem cell related genes during differentiation. Cell Cycle 2009; 8: 916–924.
24. Greer EL, Blanco MA, Gu L et al. DNA Methylation on N6-Adenine in C. elegans. Cell 2015; 161: 868–878.
25. Ougland R, Jonson I, Moen MN et al. Role of ALKBH1 in the core transcriptional network of embryonic stem cells. Cell Physiol Biochem 2016; 38: 173–184.
26. Nordstrand LM, Svärd J, Larsen E et al. Mice lacking Alkbh1 display sex-ratio distortion and unilateral eye defects. PLoS One 2010; 5: e13827.
27. Pan Z, Sikandar S, Witherspoon M et al. Impaired placental trophoblast lineage differentiation in Alkbh1(-/-) mice. Dev Dyn 2008; 237: 316–327.
28. Ougland R, Lando D, Jonson I et al. ALKBH1 is a histone H2A dioxygenase involved in neural differentiation. Stem Cells 2012; 30: 2672–2682.
29. Yuan Q, Jiang Y, Zhao X et al. Increased osteopontin contributes to inhibition of bone mineralization in FGF23-deficient mice. J Bone Miner Res 2014; 29: 693–704.
30. Chen D, Jarrell A, Guo C et al. Dermal beta-catenin activity in response to epidermal Wnt ligands is required for fibroblast proliferation and hair follicle initiation. Development 2012; 139: 1522–1533.
31. Peng L, Hu Y, Chen D et al. Ubiquitin specific peptidase 21 regulates interleukin-8 expression, stem-cell like property of human renal cell carcinoma. Oncotarget 2016; 7: 42007–42016.
32. Budnick I, Hamburg-Shields E, Chen D et al. Defining the identity of mouse embryonic dermal fibroblasts. Genesis 2016; 54: 415–430.
33. Pei M, Chen D, Li J et al. Histone deacetylase 4 promotes TGF-beta1-induced synovium-derived stem cell chondrogenesis but inhibits chon-drogenically differentiated stem cell hypertrophy. Differentiation 2009; 78: 260–268.
34. Zou H, Zhao X, Sun N et al. Effect of chronic kidney disease on the healing of titanium implants. Bone 2013; 56: 410–415.
35. Liang Y, Zhu F, Zhang H et al. Conditional ablation of TGF-beta signaling inhibits tumor progression and invasion in an induced mouse bladder cancer model. Sci Rep 2016; 6: 29479.
36. Henkel J, Woodruff MA, Epari DR et al. Bone Regeneration Based on Tissue Engineering Conceptions-A 21st Century Perspective. Bone Res 2013; 1: 216–248.
37. Kim MO, Jung H, Kim SC et al. Electromagnetic fields and nanomagnetic particles increase the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells. Int J Mol Med 2015; 35: 153–160.
38. Peng L, Ye L, Zhou XD. Mesenchymal stem cells and tooth engineering. Int J Oral Sci 2009; 1: 6–12.
39. Lee J, Abdeen AA, Kilian KA. Rewiring mesenchymal stem cell lineage specification by switching the biophysical microenvironment. Sci Rep 2014; 4: 5188.
40. Tay Y, Zhang J, Thomson AM et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 2008; 455: 1124–1128.
41. Olariu V, Lovkvist C, Sneppen K. Nanog, Oct4 and Tet1 interplay in establishing pluripotency. Sci Rep 2016; 6: 25438.
42. Ficz G, Branco MR, Seisenberger S et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011; 473: 398–402.
43. Elefteriou F, Ahn JD, Takeda S et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005; 434: 514–520.
44. Elefteriou F, Benson MD, Sowa H et al. ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae. Cell Metab 2006; 4: 441–451.
45. Yang X, Matsuda K, Bialek P et al. ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell 2004; 117: 387–398.